FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034287606> ?p ?o ?g. }

• W2034287606 endingPage "276" @default.
• W2034287606 startingPage "265" @default.
• W2034287606 abstract "CHO transfectants expressing the three subtypes of rat alpha2 adrenergic receptors (alpha2AR): alpha2D, alpha2B, alpha2C were studied to compare the transduction pathways leading to the receptor-mediated stimulation of phospholipase A2 (PLA2) in the corresponding cell lines CHO-2D, CHO-2B, CHO-2C. The alpha2B subtype stimulated the arachidonic acid (AA) release after incubation of the cells with 1 microM epinephrine, whereas alpha2D and alpha2C gave no stimulation. Calcium ionophore A23187 (1 microM) increased the release by a factor of 2-4 in the three strains. When cells were incubated with both epinephrine and Ca2+ ionophore, the AA release differed greatly between cell lines with strong potentiation in CHO-2B (2-3 times greater than Ca2+ ionophore alone), moderate potentiation in CHO-2D, and no potentiation in CHO-2C. The three cell lines each inhibited adenylylcyclase with similar efficiencies when 1 microM epinephrine was used as the agonist. The potentiation depended on both alpha2AR and Gi proteins since yohimbine and pertussis toxin inhibited the process. Pretreatment of CHO-2B cells with MAFP which inhibits both cytosolic and Ca2+-independent PLA2, reduced the release of AA induced by epinephrine+Ca2+ ionophore to basal value, whereas bromoenol lactone, a specific Ca2+-independent PLA2 inhibitor, had no effect. Preincubation of the cells with the intracellular calcium chelator BAPTA gave a dose-dependent inhibition of the arachidonic acid (AA) release. In CHO cells expressing the angiotensin II type 1 receptor, coupled to a Gq protein, the agonist (10-7 M) produced maximal AA release: there was no extra increase when angiotensin and Ca2+ ionophore were added together. There was no increase in the amount of inositol 1,4, 5-triphosphate following stimulation of CHO-2B, -2C, -2D cells with 1 microM epinephrine. Epinephrine led to greater phosphorylation of cPLA2, resulting in an electrophoretic mobility shift for all three cell lines, so inadequate p42/44 MAPKs stimulation was not responsible for the weaker stimulation of cPLA2 in CHO-2C cells. Therefore, the stimulation of cPLA2 by Gi proteins presumably involves another unknown mechanism. The differential stimulation of cPLA2 in these transfectants will be of value to study the actual involvement of the transduction pathways leading to maximal cPLA2 stimulation." @default.
• W2034287606 created "2016-06-24" @default.
• W2034287606 creator A5005998216 @default.
• W2034287606 creator A5008283195 @default.
• W2034287606 creator A5018579707 @default.
• W2034287606 creator A5030137088 @default.
• W2034287606 creator A5083951588 @default.
• W2034287606 creator A5085791496 @default.
• W2034287606 creator A5085988980 @default.
• W2034287606 date "1999-03-01" @default.
• W2034287606 modified "2023-10-16" @default.
• W2034287606 title "Differential potentiation of arachidonic acid release by rat α2 adrenergic receptor subtypes" @default.
• W2034287606 cites W1484309147 @default.
• W2034287606 cites W1504083190 @default.
• W2034287606 cites W1504432233 @default.
• W2034287606 cites W1511840890 @default.
• W2034287606 cites W1517887854 @default.
• W2034287606 cites W1519478770 @default.
• W2034287606 cites W1538690208 @default.
• W2034287606 cites W1545579092 @default.
• W2034287606 cites W1605053704 @default.
• W2034287606 cites W175842496 @default.
• W2034287606 cites W1761112651 @default.
• W2034287606 cites W1954797195 @default.
• W2034287606 cites W1978139515 @default.
• W2034287606 cites W1983461511 @default.
• W2034287606 cites W1999068708 @default.
• W2034287606 cites W2000580437 @default.
• W2034287606 cites W2014668182 @default.
• W2034287606 cites W2021238740 @default.
• W2034287606 cites W2021284850 @default.
• W2034287606 cites W2022037486 @default.
• W2034287606 cites W2027188394 @default.
• W2034287606 cites W2034634754 @default.
• W2034287606 cites W2040827725 @default.
• W2034287606 cites W2041183642 @default.
• W2034287606 cites W2042535040 @default.
• W2034287606 cites W2044535743 @default.
• W2034287606 cites W2051958752 @default.
• W2034287606 cites W2077300104 @default.
• W2034287606 cites W2088927230 @default.
• W2034287606 cites W2089219358 @default.
• W2034287606 cites W2096192238 @default.
• W2034287606 cites W2112919363 @default.
• W2034287606 cites W2116881916 @default.
• W2034287606 cites W2146388445 @default.
• W2034287606 cites W2171688276 @default.
• W2034287606 cites W2399773764 @default.
• W2034287606 cites W2414575057 @default.
• W2034287606 cites W4244721650 @default.
• W2034287606 doi "https://doi.org/10.1016/s1388-1981(99)00018-9" @default.
• W2034287606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10101261" @default.
• W2034287606 hasPublicationYear "1999" @default.
• W2034287606 type Work @default.
• W2034287606 sameAs 2034287606 @default.
• W2034287606 citedByCount "14" @default.
• W2034287606 countsByYear W20342876062016 @default.
• W2034287606 crossrefType "journal-article" @default.
• W2034287606 hasAuthorship W2034287606A5005998216 @default.
• W2034287606 hasAuthorship W2034287606A5008283195 @default.
• W2034287606 hasAuthorship W2034287606A5018579707 @default.
• W2034287606 hasAuthorship W2034287606A5030137088 @default.
• W2034287606 hasAuthorship W2034287606A5083951588 @default.
• W2034287606 hasAuthorship W2034287606A5085791496 @default.
• W2034287606 hasAuthorship W2034287606A5085988980 @default.
• W2034287606 hasConcept C126322002 @default.
• W2034287606 hasConcept C134018914 @default.
• W2034287606 hasConcept C170493617 @default.
• W2034287606 hasConcept C175656101 @default.
• W2034287606 hasConcept C181199279 @default.
• W2034287606 hasConcept C185592680 @default.
• W2034287606 hasConcept C25274449 @default.
• W2034287606 hasConcept C2776551241 @default.
• W2034287606 hasConcept C2778078955 @default.
• W2034287606 hasConcept C2778597717 @default.
• W2034287606 hasConcept C2778938600 @default.
• W2034287606 hasConcept C49773422 @default.
• W2034287606 hasConcept C55493867 @default.
• W2034287606 hasConcept C71924100 @default.
• W2034287606 hasConcept C80631254 @default.
• W2034287606 hasConcept C86803240 @default.
• W2034287606 hasConceptScore W2034287606C126322002 @default.
• W2034287606 hasConceptScore W2034287606C134018914 @default.
• W2034287606 hasConceptScore W2034287606C170493617 @default.
• W2034287606 hasConceptScore W2034287606C175656101 @default.
• W2034287606 hasConceptScore W2034287606C181199279 @default.
• W2034287606 hasConceptScore W2034287606C185592680 @default.
• W2034287606 hasConceptScore W2034287606C25274449 @default.
• W2034287606 hasConceptScore W2034287606C2776551241 @default.
• W2034287606 hasConceptScore W2034287606C2778078955 @default.
• W2034287606 hasConceptScore W2034287606C2778597717 @default.
• W2034287606 hasConceptScore W2034287606C2778938600 @default.
• W2034287606 hasConceptScore W2034287606C49773422 @default.
• W2034287606 hasConceptScore W2034287606C55493867 @default.
• W2034287606 hasConceptScore W2034287606C71924100 @default.
• W2034287606 hasConceptScore W2034287606C80631254 @default.
• W2034287606 hasConceptScore W2034287606C86803240 @default.
• W2034287606 hasIssue "3" @default.

• next